Maria Marvich

Array ( [id] => 17378343 [patent_doc_number] => 11236341 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-01 [patent_title] => RNA aptamers against transferrin receptor (TFR) [patent_app_type] => utility [patent_app_number] => 15/519074 [patent_app_country] => US [patent_app_date] => 2015-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17658 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15519074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10678334 [patent_doc_number] => 20160024480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'RECOMBINANT AAV PRODUCTION IN MAMMALIAN CELLS' [patent_app_type] => utility [patent_app_number] => 14/873498 [patent_app_country] => US [patent_app_date] => 2015-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15096 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14873498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12002141 [patent_doc_number] => 20170306296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'METHOD FOR REESTABLISHMENT OF PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 15/516107 [patent_app_country] => US [patent_app_date] => 2015-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13610 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15516107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17937047 [patent_doc_number] => 11471479 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-18 [patent_title] => Polysaccharide and nucleic acid formulations containing viscosity-lowering agents [patent_app_type] => utility [patent_app_number] => 15/516074 [patent_app_country] => US [patent_app_date] => 2015-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 32539 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15516074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13504669 [patent_doc_number] => 20180303877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-25 [patent_title] => CELL-BASED TARGETED DELIVERY OF PSEUDONOMAS EXOTOXIN [patent_app_type] => utility [patent_app_number] => 15/513385 [patent_app_country] => US [patent_app_date] => 2015-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26933 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15513385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11993954 [patent_doc_number] => 20170298109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'TUMOR ANTIGEN PEPTIDE' [patent_app_type] => utility [patent_app_number] => 15/514169 [patent_app_country] => US [patent_app_date] => 2015-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 30557 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15514169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12000311 [patent_doc_number] => 20170304465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'ADENO-ASSOCIATED VIRAL VECTORS FOR TREATING MYOCILIN (MYOC) GLAUCOMA' [patent_app_type] => utility [patent_app_number] => 15/511595 [patent_app_country] => US [patent_app_date] => 2015-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 32045 [patent_no_of_claims] => 281 [patent_no_of_ind_claims] => 98 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10489745 [patent_doc_number] => 20150374766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'ONCOLYTIC ADENOVIRUS COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/852981 [patent_app_country] => US [patent_app_date] => 2015-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 22526 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14852981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14357631 [patent_doc_number] => 10300096 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-28 [patent_title] => Use of adenoviruses and nucleic acids that code for said viruses [patent_app_type] => utility [patent_app_number] => 14/850373 [patent_app_country] => US [patent_app_date] => 2015-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 28743 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14850373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10712698 [patent_doc_number] => 20160058845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-03 [patent_title] => 'ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY' [patent_app_type] => utility [patent_app_number] => 14/839293 [patent_app_country] => US [patent_app_date] => 2015-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 27243 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14839293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11992475 [patent_doc_number] => 20170296630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'LENTIVIRAL VECTOR FOR TREATING HEMOGLOBIN DISORDERS' [patent_app_type] => utility [patent_app_number] => 15/510014 [patent_app_country] => US [patent_app_date] => 2015-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9029 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11602573 [patent_doc_number] => 20170119873 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-05-04 [patent_title] => 'SIMIAN ADENOVIRUS NUCLEIC ACID AND AMINO ACID SEQUENCES, VECTORS CONTAINING SAME, AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/824336 [patent_app_country] => US [patent_app_date] => 2015-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26225 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14824336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11602573 [patent_doc_number] => 20170119873 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-05-04 [patent_title] => 'SIMIAN ADENOVIRUS NUCLEIC ACID AND AMINO ACID SEQUENCES, VECTORS CONTAINING SAME, AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/824336 [patent_app_country] => US [patent_app_date] => 2015-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26225 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14824336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10444815 [patent_doc_number] => 20150329830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-19 [patent_title] => 'MYELOMA CELL CULTURE IN TRANSFERRIN-FREE LOW IRON MEDIUM' [patent_app_type] => utility [patent_app_number] => 14/805672 [patent_app_country] => US [patent_app_date] => 2015-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10366 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14805672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11857950 [patent_doc_number] => 09737618 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-22 [patent_title] => 'Adeno-associated virus (AAV) glades, sequences, vectors containing same, and uses therefor' [patent_app_type] => utility [patent_app_number] => 14/803683 [patent_app_country] => US [patent_app_date] => 2015-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 125 [patent_figures_cnt] => 128 [patent_no_of_words] => 25688 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14803683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11857950 [patent_doc_number] => 09737618 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-22 [patent_title] => 'Adeno-associated virus (AAV) glades, sequences, vectors containing same, and uses therefor' [patent_app_type] => utility [patent_app_number] => 14/803683 [patent_app_country] => US [patent_app_date] => 2015-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 125 [patent_figures_cnt] => 128 [patent_no_of_words] => 25688 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14803683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11755955 [patent_doc_number] => 20170202822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'METHODS AND COMPOSITIONS FOR ENHANCING CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 15/326799 [patent_app_country] => US [patent_app_date] => 2015-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16438 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11757504 [patent_doc_number] => 20170204372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'ENGINEERED CELLS FOR ADOPTIVE CELL THERAPY' [patent_app_type] => utility [patent_app_number] => 15/326441 [patent_app_country] => US [patent_app_date] => 2015-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39266 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 47 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11620021 [patent_doc_number] => 20170130208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-11 [patent_title] => 'COMPOSITIONS AND METHODS FOR PURIFYING RECOMBINANT ADENO-ASSOCIATED VIRUS' [patent_app_type] => utility [patent_app_number] => 15/322809 [patent_app_country] => US [patent_app_date] => 2015-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21170 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15322809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10489829 [patent_doc_number] => 20150374851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'AAV VECTORS EXPRESSING SEC10 FOR TREATING KIDNEY DAMAGE' [patent_app_type] => utility [patent_app_number] => 14/789159 [patent_app_country] => US [patent_app_date] => 2015-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12571 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14789159 [rel_patent_id] =>[rel_patent_doc_number] =>)